 There will be about 500 subjects taking part in this study. They will come from participating Partners Hospitals, including Brigham and Womens Hospital, Massachusetts General Hospital, Faulkner Hospital, Newton-Wellesley Hospital, Spaulding Rehabilitation Hospital, and North Shore Medical Center. The U.S. Food and Drug Administration FDA has approved warfarin for use as a blood thinner. 